Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

AVLNAVLN
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in AVALYN PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 959,098 shares of AVLN (AVALYN PHARMACEUTICALS INC), worth $31.6M as of 2026-Q2. This is a new position. AVLN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$31.6M

Current Shares

959,098

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
959,098
-
$31.6M0.0%$32.92
40

Other major holders of AVLN: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., JENNISON ASSOCIATES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used